chrisvoncsefalvay/vaers-outcomes huggingface dataset:
KNEES HURTED; SWOLLEN  ANKLES; SWOLLEN KNEES; SWOLLEN FEET; This spontaneous report received from a patient concerned a 57 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A, expiry: 21-SEP-2021) dose was not reported, administered on 03-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the patient experienced swollen ankles. On APR-2021, the patient experienced swollen knees. On APR-2021, the patient experienced swollen feet. On an unspecified date, the patient experienced knees hurted. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the swollen ankles, swollen knees, knees hurted and swollen feet was not reported. This report was non-serious.
1010 patient in general observation area. States she has tightness in chest, "feels like asthma" and "feels like someone is pressing on my chest" Denies lightheadedness or SOB. Taken to private observation area per w/c. EMT on site in attendance.  BP 148/107 in right upper arm per electronic BP machine. Recheck with manual BP in Left upper arm - 160/100; HR 84; O2 99% on room air. Noted as patient answered questions, appeared to be sl. dyspneic. Denies numbness, tingling, any pain at all, nausea, indigestion. States she drove self. States since receiving allergy shots for 6 years, she no longer has an inhaler.  1012  BP 162/124 per manual BP; HR 80; O2 99% on r/a. States that chest tightness eased, no shortness of breath. BBS CTA. Heart sounds auscultated x one minute. Strong and regular.  1027 - 158/108. Denies hx of HTN or anxiety 1035 - 168/126. States she has a slight headache since this morning, chest tightness resolved and continues to deny nausea, indigestion, pain, numbness/tingling or lightheadedness. Offered EMS for further eval/transport. Declined. Recommended patient call husband for transport. States it could take a long time. States she is well enough to drive. Recommended to contact PCP immediately regarding BP and to seek emergency attention if chest tightness returns, any SOB, nausea, onset pain esp if radiating. Patient agreed and signed. Left ambulatory, denies increase in pain/SOB, gait steady. Left via personal vehicle.
Pt is 46 yo male, employee at this institution. He is s/p Pfizer COVID-19 full vaccination: first dose on 1/21/2021, second dose on 2/11/2021. Underwent voluntary COVID-19 rapid testing on 7/14 after experiencing symptoms including fatigue, muscle or body aches, sore throat, diarrhea and congestion/runny nose. Pt reported possible exposure to COVID-19. PCR test resulted positive.
Diarrhea; She can hardly move; Side effects hit her like a ton of bricks; Headache; Body aches so bad she can hardly move; Temperature over 100F; Left arm is so sore from injection she feels like it's going to fall off.; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), MOBILITY DECREASED (She can hardly move), FEELING ABNORMAL (Side effects hit her like a ton of bricks), HEADACHE (Headache) and MYALGIA (Body aches so bad she can hardly move) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 068H21A and 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetic and Cancer.   On 15-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Dec-2021, the patient experienced DIARRHOEA (Diarrhea), MOBILITY DECREASED (She can hardly move), FEELING ABNORMAL (Side effects hit her like a ton of bricks), HEADACHE (Headache), MYALGIA (Body aches so bad she can hardly move), PYREXIA (Temperature over 100F), VACCINATION SITE PAIN (Left arm is so sore from injection she feels like it's going to fall off.) and VOMITING (Vomiting). At the time of the report, DIARRHOEA (Diarrhea), MOBILITY DECREASED (She can hardly move), FEELING ABNORMAL (Side effects hit her like a ton of bricks), HEADACHE (Headache), MYALGIA (Body aches so bad she can hardly move), PYREXIA (Temperature over 100F), VACCINATION SITE PAIN (Left arm is so sore from injection she feels like it's going to fall off.) and VOMITING (Vomiting) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100 (High) 100F.         Patient stated that she felt 50 times worse after the booster than with the 2nd dose. No relevant concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2021-052027 (Patient Link).
Pt received DTap on 1 Mar 04 in left thigh. Pt started experiencing redness later that night. The following day pt had minimal redness. Pt woke up on 3 Mar 04 with redness, sweeling up to thigh and alomost to pt's knee. Very warm to touch. Pt is limping on leg. Pt was seen by doctor and started on Benadryl and Keflex 3ml PO QID x10 days.
Extreme Migraine; Nausea; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0183) via an unspecified route of administration on 08May2021 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included triamcinolone acetonide (NASACORT) and oxymetazoline (AFRIN); for an unknown indication, on an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration on 17Apr2021 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. On 09May2021 at 10:00, the patient experienced extreme migraine, nausea and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit/ emergency visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of adverse events. The clinical outcome of the events extreme migraine, nausea and fatigue was recovered on an unknown date in May2021.  No follow-up attempts are needed. No further information is expected.
expired Moderna Covid-19 vaccine administered to 7 patient's; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired Moderna Covid-19 vaccine administered to 7 patient's) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired Moderna Covid-19 vaccine administered to 7 patient's). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired Moderna Covid-19 vaccine administered to 7 patient's) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications was reported  No treatment information was provided   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Follow-up was received on 20-JUL-2021 Does not contains any new information
Grape sized swelling near the injection Site; Grape sized swelling near the injection Site; Itchy sensation near the injection Site; Itchy sensation near the injection Site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of the first episode of VACCINATION SITE PRURITUS (Itchy sensation near the injection Site), the second episode of VACCINATION SITE PRURITUS (Itchy sensation near the injection Site), the first episode of VACCINATION SITE SWELLING (Grape sized swelling near the injection Site) and the second episode of VACCINATION SITE SWELLING (Grape sized swelling near the injection Site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced the first episode of VACCINATION SITE PRURITUS (Itchy sensation near the injection Site) and the second episode of VACCINATION SITE PRURITUS (Itchy sensation near the injection Site). On 17-Jan-2021, the patient experienced the first episode of VACCINATION SITE SWELLING (Grape sized swelling near the injection Site) and the second episode of VACCINATION SITE SWELLING (Grape sized swelling near the injection Site). At the time of the report, last episode of VACCINATION SITE PRURITUS (Itchy sensation near the injection Site) was resolving and last episode of VACCINATION SITE SWELLING (Grape sized swelling near the injection Site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Information has been received from a physician concerning a 19 year old female who on 11-SEP-2007 was vaccinated intramuscularly with her second dose of GARDASIL (lot# reported "0232U").  Within 2 minutes of getting GARDASIL, the patient experienced lightheaded and passed out.  The patient has a history of getting lightheaded with vaccines.  The patient was monitored until feeling better then left the office.  Subsequently, the patient recovered from lightheaded and passing out.  Additional information has been requested.
Swelling, soreness, heat of a lymph node on left collarbone. No treatment. Did not have a doctor look at it. The heat was gone after one day. The soreness was gone after three days. The swelling took a week to go down. There is still a very small lump.
Hepatitis A #2 given-Vaccine administered 03-10-08, but expired 03-09-08.
Dose administered to patient after temperature excursion; Temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered to patient after temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursion) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 065F21A, 038B21A and 045A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 ml. On 02-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 ml. On 02-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered to patient after temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursion). On 02-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Dose administered to patient after temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursion) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided by the reporter. Treatment information was not provided by the reporter.  Reporter stated that storage condition at the time of the excursion was frozen storage. Temperature excursion where maximum temperature for freezer was 5.36 F and minimum was (-) 1.67 Fahrenheit. On 02-Dec-2021 the vial(s) moved from freezer to refrigerator. Visual inspection noted were: looked normal, no vaccine state change.
Fatigue extreme/tired; This is a spontaneous report from a non-contactable consumer (patient). A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) as dose 1, single, with route of administration and therapy date unspecified, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient had fatigue extreme/tired/extremely fatigued. The outcome of the event was unknown.  Information about lot/batch number cannot be obtained. No follow-up attempts are possible. No further information is expected.
I21.4 ACUTE NON ST ELEVATION MI 9/30/2022 ACUTE HYPOXEMIC RESPIRATORY FAILURE
Fatigue; Pain in arm; This is a spontaneous report from a contactable consumer (patient's wife). A 76-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: EL3247), via an unspecified route of administration in right arm on 23Jan2021 at 10:30 as a single dose for COVID-19 immunisation. The patient's medical history included diabetic type 2, stent from an unspecified date in Dec2019, sulfa allergies. Concomitant medications included metformin (Strength: 500 mg) at four times a day, buspirone (Strength: 10 mg) at thrice a day, sitagliptin phosphate (JANUVIA, Strength: 50 mg), hyoscyamine sulfate (OSCIMIN, Strength: 0.125 mg), lisinopril (Strength: 5 mg) at once a day (bedtime) for BP (blood pressure), silodosin (Strength: 8 mg) at once a day (bedtime), simvastatin (ZOCOR, Strength: 40 mg) at once a day (bedtime), fish oil (Strength: 1000 mg) at twice a day, zinc (Formulation: Tablet) at once a day (in the morning), vitamin D3, cyanocobalamin (B12 20 MIL, Strength: 1000 mg) at once a day, allium sativum bulb (GARLIC EXTRACT) at 1 DF (Dosage Form), once a day (1 pill, once a day), ascorbic acid, betacarotene, biotin, calcium, chloride, chromium, copper, folic acid, iodine, lycopene, magnesium, manganese, molybdenum, nickel, nicotinic acid, pantothenic acid, phosphorus, potassium, pyridoxine hydrochloride, riboflavin, selenium, silicon, thiamine, vanadium, vitamin b12 NOS, vitamin d NOS, vitamin e NOS, vitamin k NOS, xantofyl, zinc (MEN 50+) at once a day, ubidecarenone (COQ-10, Strength: 200 mg) at once a day, exenatide (BYDUREON PEN, Formulation: Injection) at weekly (once a week on Monday) for diabetes, doxepin (Strength: 10 mg) at twice a day (bedtime). Family history was none. The patient did not receive prior vaccinations (within 4 weeks). The patient experienced pain in arm on 23Jan2021, fatigue on 24Jan2021. The patient did not require the initiation of new medication / other treatment / procedure for the events. Relevant tests was none. The outcome of the event fatigue was not recovered and recovered on an unspecified date in 2021 for the other event.
nerve damage, numbness rt leg & arm, lasting 6 months, from MAY91 to NOV91-rt knee pain from MAY91 cont on 12DEC93;
This case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a female patient who received SHINGRIX. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, unknown after receiving SHINGRIX, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown. Additional information was reported as follows: The age at vaccination was not reported. The healthcare professional reported that he vaccinated the patient only with the liquid AS01B adjuvant that was not mixed with the antigen powder for SHINGRIX, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter was asking for, how to proceed with revaccination. No further information was provided. Follow-up information was received from HCP on 21st March 2018: ---add narrative portion of source doc in narrative. On an unknown date, less than a year after vaccination with SHINGRIX, the patient experienced injection site warmth, injection site pain and injection site erythema. On an unknown date, the outcome of the injection site warmth, injection site pain and injection site erythema were unknown. No further information was provided.
got both shots and had shingles/Suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxi.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. The patient was treated with acetic acid (Apple Cider Vinegar). On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient got both shots and had shingles twice, the patient was on remedy. The patient stated that to use apple cider vinegar with the mother in it. Fab it on with cotton ball. Might sting a little but dries them (shingles) up and stops spreading. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as time to onset and laboratory confirmation for shingles were unknown at the time of reporting.
Rash 22 days following vaccination with second  Varivax. Otherwise asymptomatic.  Doing well.  No others affected to date.  Removed from school until past contagious stage.
Patient immediately had swelling form, size of half a golf ball. Patient felt fine, not difficulty breathing or history of reaction to vaccines. After a 15 minute observation period, patient was allowed to leave.
Patient was accidently given the original Pfizer shot as a booster instead of the new updated bivalent pfizer booster. no adverse events, just wrong vaccine given
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Already have all the shots. Two shots and two boosters, Pfizer vaccines". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: She already had all vaccines but recently became positive twice; Positive, notes: She already had all vaccines but recently became positive twice. Therapeutic measures were taken as a result of drug ineffective, covid-19. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Vaccinated in left leg. Right outer ear swollen, red, hot at 9:30. Stated head hurt and was scratching back of neck, forehead and ear. Mom says face looked puffy, hands and feet look puffy. Called UNC Nurse line and gave recommended dosage of children's diphenhydramine. Signs and symptoms gone by next morning.
About 3 hours after the shot my lower lip started to swell. It lasted about 24 hours.
Patient was given covid booster that expired on 4/17/23 (10 weeks in refridgerator) on 4/20/23
0.3 ML OF JNJ VACCINE ADMINISTERED AS BOOSTER OR THIRD DOSE AFTER TWO DOSES OF PFIZER VACCINE; OFF LABEL USE; This spontaneous report received from a health care professional concerned a 51 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient was previously treated with bnt 162 for prophylactic vaccination. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) .3 ml, start therapy date was not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced off label use, and 0.3 ml of JNJ vaccine administered as booster or third dose after two doses of pfizer vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the off label use and 0.3 ml of JNJ vaccine administered as booster or third dose after two doses of pfizer vaccine was not reported. This report was non-serious. This case, from the same reporter is linked to 20211045172 and 20211045076.
Basic Information  Chief Complaint   Palpitations began at 0940 today, Hx SVT, received second dose of Moderna vaccine yesterday  History of Present Illness     65F with hypothyroidism and hx of SVT, who presents with palpitations. She has had palpitations reportedly since childhood and has documented SVT on cardiac monitor in 3/2017. At baseline she has palpitations 1-4x per month, but she has had more frequent palpitations since receiving the COVID vaccine earlier this month. 2nd COVID dose yesterday. Today her palpitaitons lasted 1.5 hours prompting her to present to ED. She is asymptomatic aside from palpitations. No lightheadedness, syncope, chest pain, SOB, N/V, diaphoresis. No leg swelling. She is able to walk around while having palpitations.  She does not take rate control agents or anticoagulation.  She has plans to see her ARNP for outpatient cardiac monitoring in mid April.
Patient received the Influenza High Dose vaccine and PNEUMOVAX 23 and a few hours later was experiencing fever and headache. Arrived for the office visit next day and still had fever and HA. Will treat the Fever and HA, patient instructed to return if no better.
After my J&J vaccine, my left arm started to hurt and was tired for few days.  About three weeks later, my IBS is worse, arthritis is worse, get super tired very easily, just going up the stairs and now have to use my inhaler. I went to the see my doctor two weeks ago, he gave me an inhaler and albuterol and have hoarseness and cough way more often now than before. I can not sing anymore because I get winded.   I wish I would not have gotten the J&J vaccine due to my symptoms.
Redness on the left deltoid area. No tenderness or fever. Given Motrin.
REACTION FROM FLU SHOT. STARTED OUT AS WEAKNESS AND NAUSEA, THEN SHARP EXTREME BURNING PAIN THAT STARTED WITH MY SKULL AND WORKED DOWN MY HEAD, CHEST, ARMS, BACK AND ABDOMEN AND HIPS. PAIN FELT AS IF MY BODY WAS ON FIRE, BURNING FROM THE INSIDE OUT. FOLLWED BY CONTINUOUS VOMITING. THIS REACTION LASTED FOR AFEW HOURS. N/V LASTED OVER A DAY.